NCT00844805 Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) Status COMPLETED Phase PHASE3
NCT00811499 A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis Status TERMINATED Phase PHASE2
NCT00809159 Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis Status COMPLETED Phase PHASE2
NCT00762463 Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT00751387 Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia Status COMPLETED Phase N/A
NCT00747578 Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan Status UNKNOWN Phase N/A
NCT00722514 Evaluation of a Patient Education Program for Ankylosing Spondylitis Status COMPLETED Phase NA
NCT00715091 Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis Status COMPLETED Phase PHASE4
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT00647517 Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE4
NCT00643526 A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector Status COMPLETED Phase EARLY_PHASE1
NCT00576706 PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity Status COMPLETED Phase PHASE3
NCT00558506 Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis Status UNKNOWN Phase PHASE2
NCT00544557 Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis Status COMPLETED Phase N/A
NCT00517101 Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy Status UNKNOWN Phase N/A
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) Status COMPLETED Phase PHASE3
NCT00458185 Study Evaluating Etanercept in Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE4
NCT00444340 An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis Status COMPLETED Phase PHASE4